Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia. (Q51782486)

12 April 2018

title

Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia. (English)

1 reference

12 April 2018

single-nucleotide polymorphism

main subject

1 reference

5

1 reference

12 April 2018

David Hervás Marín

8

1 reference

12 April 2018

Jaime Sanz

object named as

Jaime Sanz

15

0 references

author name string

Juan Eduardo Megías-Vericat

1

1 reference

12 April 2018

Pau Montesinos

2

1 reference

12 April 2018

María José Herrero

3

1 reference

12 April 2018

Federico Moscardó

4

1 reference

12 April 2018

Luis Rojas

6

1 reference

12 April 2018

David Martínez-Cuadrón

7

1 reference

12 April 2018

Blanca Boluda

9

1 reference

12 April 2018

Ana García-Robles

10

1 reference

12 April 2018

Rebeca Rodríguez-Veiga

11

1 reference

12 April 2018

María Martín-Cerezuela

12

1 reference

12 April 2018

José Cervera

13

1 reference

12 April 2018

Luis Sendra

14

1 reference

12 April 2018

Antonio Miguel

16

1 reference

12 April 2018

Ignacio Lorenzo

17

1 reference

12 April 2018

José Luis Poveda

18

1 reference

12 April 2018

Miguel Ángel Sanz

19

1 reference

12 April 2018

Salvador F Aliño

20

1 reference

12 April 2018

publication date

4 October 2016

1 reference

12 April 2018

published in

Leukemia & Lymphoma

1 reference

12 April 2018

volume

58

1 reference

12 April 2018

page(s)

1197-1206

1 reference

12 April 2018

issue

5

1 reference

12 April 2018

Acute myeloid leukemia: the challenge of capturing disease variety

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Multidrug resistance-1 gene polymorphisms associated with treatment outcomes in de novo acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Prognostic value of the multidrug resistance transporter ABCG2 gene polymorphisms in Chinese patients with de novo acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

The ATP-binding cassette transporter ABCG2 (BCRP), a marker for side population stem cells, is expressed in human heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Multidrug resistance related molecules in human and murine lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1231405

10.1080/10428194.2016.1231405

21 January 2018

Identifiers

DOI

1 reference

12 April 2018

PubMed ID

27701910

1 reference

12 April 2018